Catherine Ferguson

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Nicholas D. James, Johann S. de Bono, Melissa Spears et al. · New England Journal of Medicine · 2017 · 1.8K citations · Full text

Medicine, Oncology, Urology +14

Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received

David E. Neal, Chris Metcalfe, Jenny Donovan et al. · European Urology · 2019 · 150 citations · Full text

Medicine, Surgery, Urology +17

Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer

Sameer A. Parikh, Louise Murray, Lawrence Kenning et al. · Clinical Oncology · 2018 · 58 citations

Medicine, Oncology, Urology +17

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 49 citations · Full text

Medicine, Oncology, Surgery +15

The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial

James M. Wilson, David P. Dearnaley, Isabel Syndikus et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 44 citations · Full text

Medicine, Oncology, Radiation Oncology +17